This article is representing health related news and in this topic show the viewing timetable that coalesce ultrasound and a blood experiment to notice CA125 and a indicator for ovarian cancer and the fail to realize the cancer in its untimely stage and frequently consequences in needless surgical procedure. And this is finding contrast with an extra new study that establishes that health same two test did discover untimely cancer. And taken together that expert say these studies emphasize require finding a successful show technique for this fatal cancer and this is called “silent killer.”

“The jury is still out on the efficacy of screening with CA125 and transvaginal ultrasound in terms of reducing the mortality rate of ovarian cancer,” this is said Dr. Edward Partridge and this is a institution of higher education of Alabama Birmingham cancer center.

“In this study, we do not have mortality data on the screening versus the non-screening group, so no conclusions can be made of the impact of screening with CA125 and transvaginal ultrasound,” he added.

“We learned that the positive predictive value for the combination of tests is pretty low — in the 1 to 1.3 percent range,” he said. “A substantial number of the tests are false positives.”